İçeriğe geç

Orak Hücreli Anemi (Çocuk)

Tıkayıcı Damar Hastalıklarının Tedavisi ve Akut Göğüs Sendromu

Ağrı Tedavisi

What is the best pharmacologic treatment for sickle cell disease pain crises? (yeni pencere açar)

Baker M, Hafner JW.

Kaynak‎: Ann Emerg Med 2012;59(6):515-6.

İndeks‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (yeni pencere açar)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (yeni pencere açar)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Kaynak‎: Thromb Haemost 2007;98(2):392-6.

İndeks‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (yeni pencere açar)

Hidrasyonun Sağlanması (Sıvı Tedavisi)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (yeni pencere açar)

Okomo U, Meremikwu MM.

Kaynak‎: Cochrane Database Syst Rev 2012;(6):CD005406.

İndeks‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (yeni pencere açar)

Oksijen Takviyesi

Guidelines for the management of the acute painful crisis in sickle cell disease. (yeni pencere açar)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Kaynak‎: Br J Haematol 2003;120(5):744-52.

İndeks‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (yeni pencere açar)

Antibiyotik ve Solunum Sistemi Tedavisi

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (yeni pencere açar)

Ahmad FA, Macias CG, Allen JY.

Kaynak‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

İndeks‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (yeni pencere açar)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (yeni pencere açar)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Kaynak‎: Hemoglobin 2004;28(2):85-102.

İndeks‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (yeni pencere açar)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (yeni pencere açar)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Kaynak‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

İndeks‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (yeni pencere açar)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (yeni pencere açar)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Kaynak‎: Haematologica 2013;98(9):1375-82.

İndeks‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (yeni pencere açar)

Predictors of bacteremia in febrile children with sickle cell disease. (yeni pencere açar)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Kaynak‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

İndeks‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (yeni pencere açar)